Get involved in the discussion! Click here to comment on this story
Enzymes maker Novozymes, which has repeatedly cut its 2019 sales outlook, said on Tuesday that its chief executive Peder Holk Nielsen would step down early next year as it was time to “bring in new leadership”.
“Novozymes has been challenged in recent years and needs to deliver higher revenue growth,” it said in a statement.
The Danish firm, which among other things has been struggling with a weak U.S. ethanol production after floods in the Midwest this year, said it expected to announce a new CEO within a short period of time.
Shares in the company rose almost 4% in early trade.
By Stine Jacobsen
LinkedIn Twitter FacebookTo continue to expand its position as a leading service provider in the additive manufacturing sector, BASF New Business GmbH has formally agreed to acquire the online 3D […]
LinkedIn Twitter FacebookSaudi Aramco on Sunday said it will list a 1.5% stake, or 3 billion shares, on the Tadawul (Riyadh) stock exchange in its initial public offering (IPO). The […]
LinkedIn Twitter FacebookTo improve sustainability, materials manufacturers are welcoming new digital technologies and process innovations into their global supply chains From palm oil to plastics, the global supply chains of […]